301206 三元生物
已收盘 03-21 15:00:00
资讯
新帖
简况
三元生物：将继续优化与现制茶饮客户等的战略合作推动产品认知提升
证券之星 · 03-07
三元生物：将继续优化与现制茶饮客户等的战略合作推动产品认知提升
三元生物：公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利
证券之星 · 03-07
三元生物：公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利
三元生物：2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期
证券之星 · 03-07
三元生物：2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期
三元生物：资本市场对饮料及快消品行业的青睐反映市场潜力认可
证券之星 · 03-07
三元生物：资本市场对饮料及快消品行业的青睐反映市场潜力认可
三元生物：公司将进一步加强财务法务证券等方面的专业能力建设
证券之星 · 03-07
三元生物：公司将进一步加强财务法务证券等方面的专业能力建设
三元生物：积极探索与各类饮品食品企业合作机会推动功能糖替代传统高糖产品应用
证券之星 · 03-07
三元生物：积极探索与各类饮品食品企业合作机会推动功能糖替代传统高糖产品应用
三元生物：未来几年公司将加大研发投入，特别是在提升现有产品的技术含量和开发新型功能糖领域
证券之星 · 03-07
三元生物：未来几年公司将加大研发投入，特别是在提升现有产品的技术含量和开发新型功能糖领域
三元生物：公司投资沛学生物基于技术创新性等综合评估，其尚未形成稳定盈利
证券之星 · 03-07
三元生物：公司投资沛学生物基于技术创新性等综合评估，其尚未形成稳定盈利
三元生物：公司已认真总结经验教训，并持续优化治理结构、完善内部管理
证券之星 · 03-07
三元生物：公司已认真总结经验教训，并持续优化治理结构、完善内部管理
三元生物：已启动整改工作完善财务管理体系强化长期股权投资减值测试合规性
证券之星 · 03-07
三元生物：已启动整改工作完善财务管理体系强化长期股权投资减值测试合规性
三元生物：公司始终秉持合规经营的原则认真总结过去问题优化内部管理
证券之星 · 03-07
三元生物：公司始终秉持合规经营的原则认真总结过去问题优化内部管理
三元生物：甘露醇的生产技术来源于公司自主研发
证券之星 · 03-07
三元生物：甘露醇的生产技术来源于公司自主研发
三元生物：公司业绩变化主要受行业竞争格局及市场环境变化的影响
证券之星 · 03-07
三元生物：公司业绩变化主要受行业竞争格局及市场环境变化的影响
三元生物：公司将根据市场需求和技术发展方向持续优化调整生产线布局
证券之星 · 03-07
三元生物：公司将根据市场需求和技术发展方向持续优化调整生产线布局
三元生物：阿洛酮糖生产环节主要质量控制指标包括转化率、纯度与杂质含量等
证券之星 · 03-07
三元生物：阿洛酮糖生产环节主要质量控制指标包括转化率、纯度与杂质含量等
三元生物：阿洛酮糖、塔格糖和甘露糖成为糖尿病患者和健身人群的理想选择
证券之星 · 03-07
三元生物：阿洛酮糖、塔格糖和甘露糖成为糖尿病患者和健身人群的理想选择
三元生物：公司将继续优化与渠道商及合作伙伴的战略合作
证券之星 · 03-07
三元生物：公司将继续优化与渠道商及合作伙伴的战略合作
财务不规范动摇投资者信心 三元生物需整改以重塑市场信任
每日经济新闻 · 03-03
财务不规范动摇投资者信心 三元生物需整改以重塑市场信任
股权投资减值测试存在多项违规，三元生物被责令整改
新浪证券 · 03-03
股权投资减值测试存在多项违规，三元生物被责令整改
加载更多
公司概况
公司名称：
山东三元生物科技股份有限公司
所属行业：
食品制造业
上市日期：
2022-02-10
主营业务：
山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨，是目前全球规模最大的赤藓糖醇生产企业，在赤藓糖醇行业内具有良好的口碑和较强的品牌优势，公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。
发行价格：
109.30
{"stockData":{"symbol":"301206","market":"SZ","secType":"STK","nameCN":"三元生物","latestPrice":26.11,"timestamp":1742540622000,"preClose":26.35,"halted":0,"volume":969941,"delay":0,"changeRate":-0.0091,"floatShares":108000000,"shares":202000000,"eps":0.4854,"marketStatus":"已收盘","change":-0.24,"latestTime":"03-21 15:00:00","open":26.34,"high":26.52,"low":26.01,"amount":25470400,"amplitude":0.0194,"askPrice":26.14,"askSize":13,"bidPrice":26.11,"bidSize":26,"shortable":0,"etf":0,"ttmEps":0.4854,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1742779800000},"marketStatusCode":5,"adr":0,"adjPreClose":26.35,"symbolType":"stock","openAndCloseTimeList":[[1742520600000,1742527800000],[1742533200000,1742540400000]],"highLimit":28.99,"lowLimit":23.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":202325700,"isCdr":false,"pbRate":1.18,"roa":"--","peRate":53.790688,"roe":"1.81%","epsLYR":0.29,"committee":-0.562682,"marketValue":5283000000,"turnoverRate":0.009,"status":1,"floatMarketCap":2810000000},"requestUrl":"/m/hq/s/301206","defaultTab":"news","newsList":[{"id":"2517746151","title":"三元生物：将继续优化与现制茶饮客户等的战略合作推动产品认知提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2517746151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517746151?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334265,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。共同投资建厂也罢，只要能成功可以更加打响公司品牌。公司高度重视新型功能糖在消费市场的推广与普及，未来将继续优化与包括现制茶饮客户在内的合作伙伴和渠道商的战略合作，推动相关产品认知的提升，进一步加深消费者对优质功能糖的认可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023844.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2517217460","title":"三元生物：公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517217460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517217460?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334258,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)03月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问：1、日本松谷化学授权给三元生物用于阿洛酮糖结晶的那专利，会在何时到期失去专利保护？2、该专利大概会提升产品多少成本？3、当前三元使用该专利生产的阿洛酮糖的结晶率是多少？此专利在未来是否有进一步提升阿洛酮糖结晶率的空间？谢谢董秘先生。三元生物回复：投资者您好！公司采用自主研发技术生产阿洛酮糖，并非使用日本松谷化学授权专利。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517749481","title":"三元生物：2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期","url":"https://stock-news.laohu8.com/highlight/detail?id=2517749481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517749481?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334246,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。投资者提问：看公司三季报账上有29亿多一年内到期的非流动资产是什么？具体什么时间到期，到期后公司怎么安排这29亿资产三元生物回复：投资者您好！2024年三季报中一年内到期非流动资产主要是大额存单，大部分已经到期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023783.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517117461","title":"三元生物：资本市场对饮料及快消品行业的青睐反映市场潜力认可","url":"https://stock-news.laohu8.com/highlight/detail?id=2517117461","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517117461?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:57","pubTimestamp":1741334232,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。确实，资本市场对饮料及快消品行业的青睐，反映了市场对消费品行业潜力的认可，也为像我们这样具备国际竞争力的原料供应商提供了更多机遇。我们也看到了现制茶饮及相关行业的快速增长，未来我们将加大在这些领域的业务布局，进一步推动功能糖的应用，助力公司在健康饮品和快消品市场的长远发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517174982","title":"三元生物：公司将进一步加强财务法务证券等方面的专业能力建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174982","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517174982?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:55","pubTimestamp":1741334106,"startTime":"0","endTime":"0","summary":"未来，公司将进一步加强财务、法务、证券等方面的专业能力建设，提升管理团队的规范化运作水平，以更加稳健的发展回馈投资者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023423.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301206","BK0226"],"gpt_icon":0},{"id":"2517174302","title":"三元生物：积极探索与各类饮品食品企业合作机会推动功能糖替代传统高糖产品应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174302","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517174302?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:55","pubTimestamp":1741334100,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。比如用贵公司的高甜度的健康代糖产品替换纯糖类产品。公司一直致力于推动健康代糖的普及与应用，积极探索与各类饮品、食品企业的合作机会，推动功能糖替代传统高糖产品的应用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023410.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517174996","title":"三元生物：未来几年公司将加大研发投入，特别是在提升现有产品的技术含量和开发新型功能糖领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517174996?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:54","pubTimestamp":1741334095,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。公司始终将科技创新作为核心竞争力之一，未来几年，公司将加大研发投入，特别是在提升现有产品的技术含量和开发新型功能糖领域。公司计划在优化现有生产工艺、提升产品质量和研发新产品方面进行持续投入，以应对行业竞争和市场变化，为股东创造更大价值。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517517493","title":"三元生物：公司投资沛学生物基于技术创新性等综合评估，其尚未形成稳定盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=2517517493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517517493?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:54","pubTimestamp":1741334091,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。归根到底是三元生物预测盈利至少翻倍。请注意作为上市公司的地位和一言一行三元生物回复：投资者您好！公司投资沛学生物，主要基于其核心技术创新性、市场前景及产业化潜力的综合评估，旨在推动透明质酸技术迭代及新型功能糖的研发应用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517174998","title":"三元生物：公司已认真总结经验教训，并持续优化治理结构、完善内部管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517174998?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:54","pubTimestamp":1741334089,"startTime":"0","endTime":"0","summary":"投资者提问：三元上市4年每年都收到监管函，问询函，警示函。公司始终高度重视合规经营和规范管理，对于监管关注的问题，公司已认真总结经验教训，并持续优化治理结构、完善内部管理。未来，公司将进一步加强财务、法务、证券等方面的专业能力建设，提升管理团队的规范化运作水平，同时持续优化市值管理、品牌建设和市场沟通，以更加稳健的发展回馈投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517174648","title":"三元生物：已启动整改工作完善财务管理体系强化长期股权投资减值测试合规性","url":"https://stock-news.laohu8.com/highlight/detail?id=2517174648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517174648?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:54","pubTimestamp":1741334071,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。作何感想，有什么具体行动？请澄清说明一下三元生物回复：投资者您好！公司高度重视此次监管意见，已认真分析相关问题并第一时间启动整改工作，进一步完善财务管理体系，强化长期股权投资减值测试的合规性并加强内部审计监督和财务团队建设，确保信息披露准确、透明。未来，公司将持续优化治理，稳健经营，以实际行动维护投资者利益，推动企业高质量发展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700023321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2517117180","title":"三元生物：公司始终秉持合规经营的原则认真总结过去问题优化内部管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2517117180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517117180?lang=zh_cn&edition=full","pubTime":"2025-03-07 15:48","pubTimestamp":1741333696,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月07日在投资者关系平台上答复投资者关心的问题。年年收到证监会警示函，监管函，问询函。请澄清说明清楚三元生物回复：投资者您好！公司始终秉持合规经营的原则，认真总结过去曾经出现的问题，并在此基础上不断优化内部管理和治理水平。未来，公司将继续严格遵守监管要求，强化合规体系建设，确保信息披露的透明性和准确性，以更稳健的经营回报市场和投资者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700022412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517145823","title":"三元生物：甘露醇的生产技术来源于公司自主研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145823","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517145823?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:09","pubTimestamp":1741309768,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物(301206)03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：看到公司提到正在进行赤藓糖醇产线改造，改造后可生产甘露醇产品，请问公司生产甘露醇技术来源是？与现有的甘露醇厂家对比优劣势怎样？公司在甘露醇市场布局上已经取得了哪些进展？三元生物回复：投资者您好！甘露醇的生产技术来源于公司自主研发，该产品在生产工艺和成本控制方面有一定的竞争优势。感谢您的关注与支持！以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517145801","title":"三元生物：公司业绩变化主要受行业竞争格局及市场环境变化的影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2517145801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517145801?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:09","pubTimestamp":1741309759,"startTime":"0","endTime":"0","summary":"投资者提问：3月3日的总裁办公会上，华熙生物董事长赵燕称，2024年公司步入变革调整期，但真正的变革是人的变革，现在刚刚开始。赵燕表示，“2025年公司已开始了刮骨疗毒，对于历史问题我们绝不姑息放纵，所有贪腐人员无论职务高低，必须在3月31日前交代问题、提交辞呈，否则将移交司法部门。”公司业绩变化主要受行业竞争格局及市场环境变化的影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517143046","title":"三元生物：公司将根据市场需求和技术发展方向持续优化调整生产线布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2517143046","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517143046?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:09","pubTimestamp":1741309746,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月06日在投资者关系平台上答复投资者关心的问题。公司将根据市场需求和技术发展方向，结合产品多元化战略，持续优化调整生产线布局。公司在推进技改项目时，始终坚持技术创新和成本优化，以确保新产品具备竞争力，同时推动市场拓展和客户赋能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2517214309","title":"三元生物：阿洛酮糖生产环节主要质量控制指标包括转化率、纯度与杂质含量等","url":"https://stock-news.laohu8.com/highlight/detail?id=2517214309","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517214309?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:09","pubTimestamp":1741309745,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月06日在投资者关系平台上答复投资者关心的问题。投资者提问：2月27日在投资者互动平台表示，在阿洛酮糖领域，公司目前正处于快速发展阶段，已在产能、产量、质量和能耗等方面取得显著进展，特别是在阿洛酮糖结晶提取技术上，处于行业领先水平。在阿洛酮糖的生产环节，主要质量控制指标包括转化率、纯度与杂质含量、颜色、结晶度与收率、颗粒度、溶解性和稳定性等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2517458631","title":"三元生物：阿洛酮糖、塔格糖和甘露糖成为糖尿病患者和健身人群的理想选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458631","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517458631?lang=zh_cn&edition=full","pubTime":"2025-03-07 09:03","pubTimestamp":1741309403,"startTime":"0","endTime":"0","summary":"阿洛酮糖、塔格糖和甘露糖在功能性食品和中高端健康食品中已得到不同程度的应用，特别是在低热量、不升血糖的需求下，成为糖尿病患者和健身人群的理想选择。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007179.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2517436781","title":"三元生物：公司将继续优化与渠道商及合作伙伴的战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2517436781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517436781?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:57","pubTimestamp":1741309028,"startTime":"0","endTime":"0","summary":"证券之星消息，三元生物03月06日在投资者关系平台上答复投资者关心的问题。公司高度重视新型功能糖在消费市场的推广与普及，未来将继续优化与渠道商及合作伙伴的战略合作，推动相关产品认知的提升，进一步加深消费者对优质功能糖的认可。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030700007067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301206","BK0226"],"gpt_icon":0},{"id":"2516152052","title":"财务不规范动摇投资者信心 三元生物需整改以重塑市场信任","url":"https://stock-news.laohu8.com/highlight/detail?id=2516152052","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516152052?lang=zh_cn&edition=full","pubTime":"2025-03-03 09:54","pubTimestamp":1740966840,"startTime":"0","endTime":"0","summary":" 近日，三元生物收到山东证监局的《责令改正决定书》和《警示函决定书》，引发市场关注。在2023年末对长期股权投资进行减值测试时 ，公司存在收入增长率、净经营资产增长率、折现率等指标选取依据不充分，部分指标选取不恰当以及未考虑所持股权比例等问题，这严重违反了相关会计准则和信息披露管理办法。 三元生物应迅速采取有效整改措施，完善内部财务管理制度，加强人员培训，提升财务核算水平和信息披露质量。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-03-03/doc-ineniuqm2614617.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-03-03/doc-ineniuqm2614617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0},{"id":"2516249365","title":"股权投资减值测试存在多项违规，三元生物被责令整改","url":"https://stock-news.laohu8.com/highlight/detail?id=2516249365","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516249365?lang=zh_cn&edition=full","pubTime":"2025-03-03 09:38","pubTimestamp":1740965880,"startTime":"0","endTime":"0","summary":" 3月3日，山东证监局发布了一则《关于对山东三元生物科技股份有限公司采取责令改正措施的决定》，对山东三元生物科技股份有限公司采取责令改正的监管措施，并记入证券期货市场诚信档案数据库。 公告显示，2022 年 11 月，三元生物对外投资 6000 万元，持有山东沛学生物工程有限公司的股权，并确认为长期股权投资，采用权益法进行后续计量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2025-03-03/doc-ineniuqq6844213.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0226","301206"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1742634881322,"stockEarnings":[{"period":"1week","weight":-0.0268},{"period":"1month","weight":0.0349},{"period":"3month","weight":-0.0376},{"period":"6month","weight":0.1435},{"period":"1year","weight":0.0652},{"period":"ytd","weight":0.0062}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.001},{"period":"6month","weight":0.2295},{"period":"1year","weight":0.0935},{"period":"ytd","weight":0.0039}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东三元生物科技股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"13602人(较上一季度增加0.10%)","perCapita":"7911股","listingDate":"2022-02-10","address":"山东省滨州市滨城区滨北张富路89号","registeredCapital":"20232万元","survey":" 山东三元生物科技股份有限公司主营业务是功能糖赤藓糖醇和阿洛酮糖产品的研发、生产和销售。公司的主要产品是赤藓糖醇及复配糖、阿洛酮糖。公司主要产品赤藓糖醇生产能力为13.5万吨，是目前全球规模最大的赤藓糖醇生产企业，在赤藓糖醇行业内具有良好的口碑和较强的品牌优势，公司生产的天绿原牌赤藓糖醇被评为“山东优质品牌”和“山东知名品牌”。","listedPrice":109.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三元生物,301206,三元生物股票,三元生物股票老虎,三元生物股票老虎国际,三元生物行情,三元生物股票行情,三元生物股价,三元生物股市,三元生物股票价格,三元生物股票交易,三元生物股票购买,三元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三元生物(301206)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三元生物(301206)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}